MYO5A and TRIM3

  • Number of citations of the paper that reports this interaction (PMID 10391919)
  • 16
  • Data Source:
  • HPRD (in vivo, two hybrid)

MYO5A

TRIM3

Gene Name myosin VA (heavy chain 12, myoxin) tripartite motif containing 3
Image No pdb structure No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 11 interactors: BMF DLGAP1 DYNLL1 DYNLL2 MLPH NEFL PRPH RAB11A RAB27A TRIM2 TRIM3 8 interactors: ACTN4 KIF21B MYO5A TNFAIP3 UBE2D4 UBE2G2 UBE2K UBE2U
Entrez ID 4644 10612
HPRD ID 01179 05690
Ensembl ID ENSG00000197535 ENSG00000110171
Uniprot IDs A8CDT9 F8WE88 G3V394 Q9UES4 Q9Y4I1 B7Z5Y8 O75382
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
agouti  camk2g  cd47  chances  clstn2  consonant  enpp1  epha5a  gad2  gria3  grin2b  kif  minipumps  negr1  neuroplasticity  ntrk2  ntrk3  ppp3r1  prdx1  predecessors  serotonine  slc2a4  sv2b  syn2  synaptogenesis  synj2  therapeutical  venlafaxine  vlx 
amplifying  bona  brat  depends  exit  fide  ht2a  lin41  mei  named  ncl1  nhl  p26  perturb  phenotypes  preferred  progenitor  reconstituted  repeat  ring  subfamily  suppress  suppressive  transit  tripartite  ubch5a  ubiquitinate  ubiquitination 
Tagcloud (Difference) ?
agouti  camk2g  cd47  chances  clstn2  consonant  enpp1  epha5a  gad2  gria3  grin2b  kif  minipumps  negr1  neuroplasticity  ntrk2  ntrk3  ppp3r1  prdx1  predecessors  serotonine  slc2a4  sv2b  syn2  synaptogenesis  synj2  therapeutical  venlafaxine  vlx 
amplifying  bona  brat  depends  exit  fide  ht2a  lin41  mei  named  ncl1  nhl  p26  perturb  phenotypes  preferred  progenitor  reconstituted  repeat  ring  subfamily  suppress  suppressive  transit  tripartite  ubch5a  ubiquitinate  ubiquitination 
Tagcloud (Intersection) ?